Smartest Doc
Test your clinical knowledge against other physicians in the USA by taking our FREE daily quiz!
We invite you to take the "Board Exam Prep Quiz"
Assess your general knowledge at the topic level with your personalized scorecard.
Gowrishankar K et al. – The data indicate that melanoma tumors are likely to develop heterogeneous mechanisms of resistance, many of which will confer resistance to multiple mitogen–activated protein kinase (MAPK) inhibitory therapies.
Your Unread Messages in Oncology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Smartest Doc Challenge
MDLinx
Today Only! We’re helping you prep for your board exams
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Markers of obesity and inflammation in postmenopausal breast cancer
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
